Alterola Biotech, Inc.: capital expenditure payments

What this measure means

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Exact concept: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2009-10-01 to 2013-09-30. The SEC response was captured on 2026-09-21.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Related financial histories

• Alterola Biotech, Inc.: total assets
• Alterola Biotech, Inc.: total liabilities
• Alterola Biotech, Inc.: stockholders equity
• Alterola Biotech, Inc.: cash and cash equivalents
• Alterola Biotech, Inc.: net income or loss
• Alterola Biotech, Inc.: operating cash flow
• Alterola Biotech, Inc.: revenue
• Alterola Biotech, Inc.: financing cash flow
• Alterola Biotech, Inc.: investing cash flow
• Alterola Biotech, Inc.: retained earnings or deficit
• Alterola Biotech, Inc.: income tax expense or benefit
• Alterola Biotech, Inc.: share-based compensation expense
• Alterola Biotech, Inc.: operating income or loss
• Alterola Biotech, Inc.: current assets
• Alterola Biotech, Inc.: interest expense
• Alterola Biotech, Inc.: current liabilities
• Alterola Biotech, Inc.: current accounts payable
• Alterola Biotech, Inc.: operating expenses
• Alterola Biotech, Inc.: net inventory
• Alterola Biotech, Inc.: research and development expense
• Alterola Biotech, Inc.: common shares outstanding
• Alterola Biotech, Inc.: cash including restricted cash
• Alterola Biotech, Inc.: additional paid-in capital
• Alterola Biotech, Inc.: long-term debt
• Alterola Biotech, Inc.: accrued current liabilities
• Alterola Biotech, Inc.: net deferred tax assets
• Alterola Biotech, Inc.: net income available to common stockholders
• Alterola Biotech, Inc.: general and administrative expense
• Alterola Biotech, Inc.: amortization of intangible assets
• Alterola Biotech, Inc.: other nonoperating income or expense
• Alterola Biotech, Inc.: current income tax expense or benefit
• Alterola Biotech, Inc.: proceeds from issuing common stock
• Alterola Biotech, Inc.: change in inventories
• Alterola Biotech, Inc.: change in accounts payable

Inspect the source

Entity

Alterola Biotech, Inc. / CIK 0001442999

Captured

2026-09-21T17:19:50.475Z

SEC response SHA-256

87a3a16f9156f52960516ff7604a147caa80abebfe964591df0bd913491df844

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001442999.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))